Hikal is currently trading at Rs. 134.20, up by 0.20 points or 0.15% from its previous closing of Rs. 134.00 on the BSE.
The scrip opened at Rs. 136.00 and has touched a high and low of Rs. 139.00 and Rs. 134.00 respectively. So far 127 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 167.00 on 02-Jan-2015 and a 52 week low of Rs. 85.44 on 16-May-2014.
Last one week high and low of the scrip stood at Rs. 147.50 and Rs. 131.00 respectively. The current market cap of the company is Rs. 1103.13 crore.
The promoters holding in the company stood at 68.77% while Institutions and Non-Institutions held 14.51% and 16.72% respectively.
Hikal has received an approval for raising funds up to an amount of Rs 125 crore, by issuing equity shares. The board of directors at their meeting held on May 5, 2015 has approved for the same.
The company will raise funds by issuing equity shares through qualified institutions placement and / or issue of warrants / equity shares / such other permissible securities on such terms and conditions as may be decided by the board of directors and / or committee of the board, subject to approval of the members of the company.
Hikal is a provider of solutions & reliable long-term outsourcing partner to companies in the Pharmaceuticals, Crop Protection, Animal health, and Specialty Chemicals industry. The company has been supplying key active ingredients (AI) and intermediates, manufactured using stringent global quality standards, for its customers in the United States, Europe and Japan
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |